{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:06:22Z","timestamp":1774353982139,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20244Y0147"],"award-info":[{"award-number":["20244Y0147"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["22XD1422700"],"award-info":[{"award-number":["22XD1422700"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270114"],"award-info":[{"award-number":["82270114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.amjms.2025.08.019","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:07:05Z","timestamp":1755875225000},"page":"574-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful treatment of refractory gastroesophageal reflux-induced chronic cough with vonoprazan: a report of three cases"],"prefix":"10.1016","volume":"370","author":[{"given":"Tong-Yang-Zi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-Di","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Guang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Huai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.amjms.2025.08.019_bib0001","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.019_bib0002","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1378\/chest.12-0441","article-title":"A prospective, multicenter survey on causes of chronic cough in China","volume":"143","author":"Lai","year":"2013","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.019_bib0003","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.chest.2016.08.1458","article-title":"Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report","volume":"150","author":"Kahrilas","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.019_bib0004","first-page":"178","article-title":"A stepwise protocol for the treatment of refractory gastroesophageal reflux-induced chronic cough","volume":"8","author":"Xu","year":"2016","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.019_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5662\/wjm.v5.i3.149","article-title":"Refractory chronic cough due to gastroesophageal reflux: definition, mechanism and management","volume":"5","author":"Lv","year":"2015","journal-title":"World J Methodol"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.019_bib0006","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/apt.15169","article-title":"Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough","volume":"49","author":"Dong","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.019_bib0007","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00535-022-01861-z","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021","volume":"57","author":"Iwakiri","year":"2022","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.019_bib0008","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/apt.15641","article-title":"Randomised trial of acid inhibition by vonoprazan 10\/20 mg once daily vs rabeprazole 10\/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)","volume":"51","author":"Takeuchi","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.019_bib0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10620-020-06141-5","article-title":"Direct comparison of the efficacy and safety of Vonoprazan versus proton-pump inhibitors for gastroesophageal reflux disease: a systematic review and meta-analysis","volume":"66","author":"Cheng","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.019_bib0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4168\/aair.2024.16.2.191","article-title":"Potassium-competitive acid blocker versus proton pump inhibitor: a pilot study on comparable efficacy in the treatment of gastroesophageal reflux-related cough","volume":"16","author":"Zhong","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.019_bib0011","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00408-025-00815-5","article-title":"Efficacy and safety of Fexuprazan versus Esomeprazole for gastroesophageal reflux disease-related chronic cough: a randomized, double-blind, active-controlled exploratory trial","volume":"203","author":"Kang","year":"2025","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.019_bib0012","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00408-016-9937-5","article-title":"Reliability and validity of the Swedish version of the Hull airway reflux questionnaire (HARQ-S)","volume":"194","author":"Johansson","year":"2016","journal-title":"Lung"},{"issue":"23","key":"10.1016\/j.amjms.2025.08.019_bib0013","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.21037\/atm-20-3236","article-title":"Sensitivity and specificity of combination of Hull airway reflux questionnaire and gastroesophageal reflux disease questionnaire in identifying patients with gastroesophageal reflux-induced chronic cough","volume":"8","author":"Wen","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.amjms.2025.08.019_bib0014","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.1378\/chest.129.1_suppl.80S","article-title":"Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Irwin","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.019_bib0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","article-title":"Management of heartburn not responding to proton pump inhibitors","volume":"58","author":"Fass","year":"2009","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.amjms.2025.08.019_bib0016","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2036.2011.04583.x","article-title":"Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor","volume":"33","author":"Hershcovici","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.019_bib0017","doi-asserted-by":"crossref","first-page":"577","DOI":"10.5056\/jnm18036","article-title":"Pathophysiology of potassium-competitive acid blocker-refractory gastroesophageal reflux and the potential of potassium-competitive acid blocker test","volume":"24","author":"Masaoka","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"issue":"8","key":"10.1016\/j.amjms.2025.08.019_bib0018","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/apt.13384","article-title":"Editorial: towards extended acid suppression\u2013the search continues","volume":"42","author":"Scarpignato","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjms.2025.08.019_bib0019","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/apt.13414","article-title":"The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase [published correction appears in Aliment Pharmacol Ther. 2016 Jan;43(2):315]","volume":"42","author":"Scott","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.019_bib0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/17425255.2018.1461835","article-title":"Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine","volume":"14","author":"El Rouby","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"10","key":"10.1016\/j.amjms.2025.08.019_bib0021","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/apt.13588","article-title":"Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype","volume":"43","author":"Kagami","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.019_bib0022","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cpt.2015","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing","volume":"109","author":"Lima","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.019_bib0023","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/crj.12124","article-title":"Comparison of clinical characteristics of chronic cough due to non-acid and acid gastroesophageal reflux","volume":"9","author":"Xu","year":"2015","journal-title":"Clin Respir J"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.019_bib0024","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/apt.15062","article-title":"Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis","volume":"49","author":"Oshima","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.019_bib0025","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2036.2006.03235.x","article-title":"Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis","volume":"25","author":"Katz","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.019_bib0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/br.2016.828","article-title":"Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia","volume":"6","author":"Asaoka","year":"2017","journal-title":"Biomed Rep"},{"issue":"6","key":"10.1016\/j.amjms.2025.08.019_bib0027","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/apt.13331","article-title":"Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis","volume":"42","author":"Ashida","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.019_bib0028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000368766","article-title":"Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring","volume":"91","author":"Kawamura","year":"2015","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.019_bib0029","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","article-title":"Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease\u2013where next?","volume":"22","author":"Fass","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.amjms.2025.08.019_bib0030","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019520","article-title":"Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease","volume":"99","author":"Gotoh","year":"2020","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.019_bib0031","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3892\/br.2017.947","article-title":"Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease","volume":"7","author":"Shinozaki","year":"2017","journal-title":"Biomed Rep"},{"issue":"17","key":"10.1016\/j.amjms.2025.08.019_bib0032","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2169\/internalmedicine.0492-17","article-title":"Efficacy of Vonoprazan for gastroesophageal reflux symptoms in patients with proton pump inhibitor-resistant non-erosive reflux disease","volume":"57","author":"Niikura","year":"2018","journal-title":"Intern Med"},{"issue":"12","key":"10.1016\/j.amjms.2025.08.019_bib0033","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.kjms.2017.07.004","article-title":"Vonoprazan treatment improves gastrointestinal symptoms in patients with gastroesophageal reflux disease","volume":"33","author":"Shinozaki","year":"2017","journal-title":"Kaohsiung J Med Sci"},{"issue":"3","key":"10.1016\/j.amjms.2025.08.019_bib0034","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10388-020-00798-7","article-title":"Efficacy of vonoprazan 10 mg compared with 20 mg for the initial treatment in patients with erosive esophagitis: a randomized pilot study","volume":"18","author":"Okanobu","year":"2021","journal-title":"Esophagus"},{"issue":"1","key":"10.1016\/j.amjms.2025.08.019_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14468","volume":"35","author":"Tack","year":"2023","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"10.1016\/j.amjms.2025.08.019_bib0036","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10388-018-00654-9","article-title":"Efficacy of on-demand therapy using 20-mg vonoprazan for non-erosive reflux disease","volume":"16","author":"Hoshikawa","year":"2019","journal-title":"Esophagus"},{"issue":"5","key":"10.1016\/j.amjms.2025.08.019_bib0037","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jgf2.429","article-title":"Treatment strategies for reflux esophagitis including a potassium-competitive acid blocker: a cost-effectiveness analysis in Japan","volume":"22","author":"Habu","year":"2021","journal-title":"J Gen Fam Med"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.019_bib0038","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s12328-021-01437-z","article-title":"Marked reduction in the number of white globe appearance lesions in the noncancerous stomach after exchanging vonoprazan for esomeprazole treatment: a follow-up case report","volume":"14","author":"Miwa","year":"2021","journal-title":"Clin J Gastroenterol"},{"issue":"4","key":"10.1016\/j.amjms.2025.08.019_bib0039","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2169\/internalmedicine.3715-19","article-title":"Vonoprazan-associated gastric mucosal redness: a report of four cases","volume":"59","author":"Kubo","year":"2020","journal-title":"Intern Med"},{"issue":"12","key":"10.1016\/j.amjms.2025.08.019_bib0040","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1080\/00365521.2022.2097893","article-title":"Long-term changes in serum gastrin levels during standard dose vonoprazan therapy","volume":"57","author":"Shinozaki","year":"2022","journal-title":"Scand J Gastroenterol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296292501153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296292501153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T01:18:29Z","timestamp":1772846309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296292501153X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S000296292501153X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.08.019","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of refractory gastroesophageal reflux-induced chronic cough with vonoprazan: a report of three cases","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}